Monique van Wolferen is a Researcher and Teacher at Utrecht University's Faculty of Veterinary Medicine, Department of Clinical Sciences, specializing in Internal Medicine of Companion Animals. She is actively involved in cutting-edge research on veterinary internal medicine, with a particular focus on organoid technology and hepatic diseases in companion animals. Her primary research interests center around organoid development for veterinary applications , particularly in modeling hepatic diseases in dogs and cats. Her work spans from basic organoid culture techniques to translational applications for disease modeling and potential therapies. She has made significant contributions to understanding canine copper storage disease, hepatic lipidosis in cats, and developing innovative organoid-based models for various liver conditions. Analysis of her recent publications reveals a strong focus on translational veterinary medicine , with particular emphasis on organoid technology applications. Her research demonstrates a progression from basic organoid culture development toward increasingly complex applications including multi-organ systems, bioprinting, and therapeutic testing. The work spans multiple species (primarily dogs and cats) and addresses both fundamental biological questions and clinically relevant problems in veterinary medicine. While no specific scientific awards are listed in the available information, her research has garnered significant attention as evidenced by high citation counts on several publications, including over 300 citations for her work on volumetric bioprinting of organoids. Van Wolferen supervises students from both Utrecht University of Applied Sciences and the Veterinary Medicine program. Her research appears to be well-funded, supporting extensive work in organoid development and disease modeling, though specific grant details are not provided in the available information. Her laboratory work focuses on companion animal organoid systems , particularly for liver diseases. The research group appears to specialize in developing and applying organoid technology to model various hepatic conditions in dogs and cats, with applications ranging from basic disease mechanisms to potential therapeutic testing.



